Published February 18, 2013
Stephen Rudin, PhD, director of radiology’s radiation physics division, has won a four-year, $2.5 million grant from the National Institutes of Health to continue developing state-of-the-art technology within a new class of imaging detectors.
Rudin’s research has the potential to translate into manufactured medical systems providing new standards of care in neurovascular medicine.
Rudin and other collaborators are furthering the development of a high-resolution, region-of-interest X-ray imaging detector.
With qualities superior to standard X-ray image intensifiers and flat panel detectors, the micro-angiographic fluoroscope (MAF) will provide better images while minimizing patients’ radiation doses.
Rudin’s research, funded through the National Institute of Biomedical Imaging and Bioengineering, seeks to improve image-guided neurovascular diagnosis and refine neurovascular interventions.
The MAF was constructed by Rudin and his collaborators during earlier phases of research.
Recently, they achieved promising results after using the MAF to guide human interventions.
Moving forward, their research will focus on enhancing the detector system technology. They plan to continue testing on patients as developments are implemented.
While the researchers are focused on neurovascular applications, they believe their developing medical imaging concepts may apply to all endovascular procedures, including cardiovascular diagnoses and interventions, peripheral vascular diagnoses and intervention, and pediatric procedures.
Rudin, a SUNY Distinguished Professor, is joined by several UB collaborators, including:
Michael Silver, PhD, vice president for research at Toshiba Medical Research Institute USA, is also working on the project.